Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-16 Purchase | 2024-05-20 9:33 pm | Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director | 1,724,137 | $2.9 | $4,999,997 | 10,099,279 (Indirect Direct) | View |
| 2022-01-12 Purchase | 2022-01-14 12:02 pm | Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director | 155,039 | $12.6 | $1,953,491 | 7,075,233 (Indirect Direct) | View |
| 2020-06-04 Purchase | 2020-06-04 4:04 pm | Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director | 146,382 | $47 | $6,879,954 | 6,447,492 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-06 Option Award | 2024-08-08 09:11 am | N/A 2034-08-06 | UroGen Pharma Ltd. | URGN | Belldegrun Arie Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-06-25 Option Award | 2024-06-26 4:31 pm | N/A 2034-06-24 | Kronos Bio Inc. | KRON | Belldegrun Arie Director | 34,000 | $0 | 34,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 4:26 pm | N/A N/A | Ginkgo Bioworks Holdings Inc. | DNA | Belldegrun Arie Director | 1,004,328 | $0 | 1,699,253 (Direct) | View |
| 2024-06-12 Exercise | 2024-06-14 4:26 pm | N/A N/A | Ginkgo Bioworks Holdings Inc. | DNA | Belldegrun Arie Director | 105,263 | $0 | 1,699,253 (Direct) | View |
| 2024-05-16 Option Award | 2024-05-20 9:33 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director | 344,828 | $2.9 | 10,099,279 (Indirect) | View |
| 2024-01-25 Option Award | 2024-01-31 5:46 pm | N/A 2034-01-25 | Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director | 961,371 | $0 | 9,319,579 (Direct) | View |
| 2023-09-07 Option Award | 2023-09-08 3:43 pm | N/A 2033-09-07 | UroGen Pharma Ltd. | URGN | Belldegrun Arie Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-26 4:08 pm | N/A 2033-06-21 | Kronos Bio Inc. | KRON | Belldegrun Arie Director | 34,000 | $0 | 34,000 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 5:03 pm | N/A N/A | Ginkgo Bioworks Holdings Inc. | DNA | Belldegrun Arie Director | 245,123 | $0 | 245,123 (Direct) | View |
| 2023-03-22 Option Award | 2023-03-24 8:14 pm | N/A 2033-03-22 | Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director | 2,277,776 | $0 | 9,353,008 (Direct) | View |
| 2022-09-14 Exercise | 2022-09-16 3:13 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Belldegrun Arie Director | 160,000 | $5 | 408,693 (Direct) | View |
| 2022-09-14 Exercise | 2022-09-16 3:13 pm | 2019-10-07 2022-10-07 | UroGen Pharma Ltd. | URGN | Belldegrun Arie Director | 160,000 | $0 | 408,693 (Direct) | View |
| 2022-08-31 Exercise | 2022-09-02 11:40 am | N/A N/A | UroGen Pharma Ltd. | URGN | Belldegrun Arie Director | 3,241 | $5 | 248,693 (Direct) | View |
| 2022-08-31 Exercise | 2022-09-02 11:40 am | 2015-09-01 2022-09-01 | UroGen Pharma Ltd. | URGN | Belldegrun Arie Director | 3,241 | $0 | 248,693 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-29 4:06 pm | N/A 2032-06-21 | Kronos Bio Inc. | KRON | Belldegrun Arie Director | 34,000 | $0 | 34,000 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-13 9:13 pm | N/A 2032-06-10 | Ginkgo Bioworks Holdings Inc. | DNA | Belldegrun Arie Director | 179,437 | $0 | 698,178 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 3:37 pm | N/A 2032-06-08 | UroGen Pharma Ltd. | URGN | Belldegrun Arie Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-03-14 Other(A) | 2022-04-01 5:40 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director | 4,710,120 | $0 | 14,502,270 (Indirect) | View |
| 2022-03-14 Other | 2022-03-31 5:27 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director | 4,710,121 | $0 | 16,495,448 (Indirect) | View |
Ownership(A) | 2022-03-28 5:30 pm | N/A N/A | Ginkgo Bioworks Holdings Inc. | DNA | Belldegrun Arie Director | 0 | $0 | 522,489 (Direct) | View |
| 2022-03-23 Option Award | 2022-03-25 5:50 pm | N/A 2032-03-23 | Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director | 1,458,333 | $0 | 1,458,333 (Direct) | View |
| 2021-06-22 Option Award | 2021-06-23 9:14 pm | N/A 2031-06-21 | Kronos Bio Inc. | KRON | Belldegrun Arie Director | 20,600 | $0 | 20,600 (Direct) | View |
| 2021-03-26 Exercise(A) | 2021-06-09 1:47 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Belldegrun Arie Director | 3,241 | $5 | 245,452 (Direct) | View |
| 2021-03-26 Exercise(A) | 2021-06-09 1:47 pm | 2014-07-27 2021-07-27 | UroGen Pharma Ltd. | URGN | Belldegrun Arie Director | 3,241 | $0 | 245,452 (Direct) | View |
| 2021-06-07 Option Award | 2021-06-09 1:41 pm | N/A 2031-06-06 | UroGen Pharma Ltd. | URGN | Belldegrun Arie Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-05-24 Exercise | 2021-05-25 08:00 am | N/A N/A | Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director | 379,066 | $18.22 | 6,920,193 (Direct) | View |
| 2021-05-24 Exercise | 2021-05-25 08:00 am | N/A 2030-03-18 | Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director | 379,066 | $0 | 6,920,193 (Direct) | View |
| 2021-03-24 Exercise | 2021-04-22 5:19 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Belldegrun Arie Director | 3,241 | $5 | 245,452 (Direct) | View |
| 2021-03-24 Exercise | 2021-04-22 5:19 pm | 2014-07-27 2021-07-27 | UroGen Pharma Ltd. | URGN | Belldegrun Arie Director | 3,241 | $0 | 245,452 (Direct) | View |
| 2021-03-26 Option Award | 2021-03-30 5:00 pm | N/A 2031-03-26 | Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director | 252,858 | $0 | 6,740,350 (Direct) | View |
| 2020-10-14 Conversion | 2020-10-16 3:44 pm | N/A N/A | Kronos Bio Inc. | KRON | Belldegrun Arie Director | 253,251 | $16.15 | 2,315,314 (Indirect) | View |
| 2020-10-14 Conversion | 2020-10-16 3:44 pm | N/A N/A | Kronos Bio Inc. | KRON | Belldegrun Arie Director | 8,932,028 | $0 | 2,315,314 (Indirect) | View |
Ownership | 2020-10-08 7:07 pm | N/A N/A | Kronos Bio Inc. | KRON | Belldegrun Arie Director 10% Owner | 0 | $0 | 2,994,889 (Indirect) | View |
| 2020-06-08 Option Award | 2020-06-10 6:35 pm | N/A 2030-06-07 | UroGen Pharma Ltd. | URGN | Belldegrun Arie Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2020-03-18 Option Award | 2020-03-20 4:38 pm | N/A 2030-03-17 | Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director | 379,066 | $0 | 379,066 (Direct) | View |